7/29/2025

Potassium Chloride Injection

Products Affected - Description

- Potassium chloride injection, Pfizer, 2 mEq/mL, 10 mL vial, 25 count, NDC 00409-6651-06
- Potassium chloride injection, Nexus Pharmaceuticals, 10 mEq/100 mL, sterile water premixed bag, 24 count, NDC 14789-0109-10
- Potassium chloride injection, Nexus Pharmaceuticals, 10 mEq/50 mL, sterile water premixed bag, 24 count, NDC 14789-0108-05
- Potassium chloride injection, Nexus Pharmaceuticals, 20 mEq/100 mL, sterile water premixed bag, 24 count, NDC 14789-0108-10
- Potassium chloride injection, Nexus Pharmaceuticals, 20 mEq/50 mL, sterile water premixed bag, 24 count, NDC 14789-0107-05

Reason for the Shortage

- Baxter has potassium chloride available.
- BBraun has potassium chloride available.
- ICU Medical has potassium chloride available.
- Fresenius Kabi has potassium chloride available.
- Nexus did not provide a reason for the shortage.
- Pfizer has potassium chloride on shortage due to increased demand.

Available Products

- Potassium chloride injection, BBraun, 2 mEq/mL, 100 mL bulk package 24 count, NDC 00264-1944-20
- Potassium chloride injection, Fresenius Kabi, 2 mEq/mL, 10 mL vial, 25 count, NDC 63323-0965-10
- Potassium chloride injection, Fresenius Kabi, 2 mEq/mL, 20 mL vial, 25 count, NDC 63323-0965-20
- Potassium chloride injection, Fresenius Kabi, 2 mEq/mL, 30 mL vial, 25 count, NDC 63323-0967-30
- Potassium chloride injection, Fresenius Kabi, 2 mEq/mL, 5 mL vial, 25 count, NDC 63323-0965-05
- Potassium chloride injection, Pfizer, 2 mEq/mL, 20 mL vial, 25 count, NDC 00409-6653-05
- Potassium chloride injection, Pfizer, 2 mEq/mL, 5 mL vial, 25 count, NDC 00409-6635-01
- Potassium chloride injection, Baxter, 10 mEq/100 mL, sterile water Viaflex container, 24 count, NDC 00338-0709-48
- Potassium chloride injection, Baxter, 10 mEq/50 mL, sterile water Viaflex container, 24 count, NDC 00338-0705-41
- Potassium chloride injection, Baxter, 20 mEq/100 mL, sterile water Viaflex container, 24 count, NDC 00338-0705-48
- Potassium chloride injection, Baxter, 20 mEq/50 mL, sterile water Viaflex container, 24 count, NDC 00338-0703-41
- Potassium chloride injection, Baxter, 40 mEq/100 mL, sterile water Viaflex container, 24 count, NDC 00338-0703-48
- Potassium chloride injection, Fresenius Kabi, 10 mEq/100 mL, sterile water freeflex bag, 50 count, NDC 65219-0012-01
- Potassium chloride injection, Fresenius Kabi, 10 mEq/50 mL, sterile water freeflex bag, 60 count, NDC 65219-0004-01
- Potassium chloride injection, Fresenius Kabi, 20 mEq/100 mL, sterile water freeflex bag, 50 count, NDC 65219-0006-01
- Potassium chloride injection, Fresenius Kabi, 20 mEq/50 mL, sterile water freeflex bag, 60 count, NDC 65219-0008-51
- Potassium chloride injection, Fresenius Kabi, 40 mEq/100 mL, sterile water freeflex bag, 50 count, NDC 65219-0010-01
- Potassium chloride injection, ICU Medical, 10 mEq/100 mL, sterile water 24 count, NDC 00990-7074-26
- Potassium chloride injection, ICU Medical, 10 mEq/50 mL, sterile water 24 count, NDC 00990-7075-14
- Potassium chloride injection, ICU Medical, 20 mEq/100 mL, sterile water 24 count, NDC 00990-7075-26
- Potassium chloride injection, ICU Medical, 20 mEq/50 mL, sterile water 24 count, NDC 00990-7077-14
- Potassium chloride injection, ICU Medical, 40 mEq/100 mL, sterile water 24 count, NDC 00990-7077-26

Estimated Resupply Dates

- Pfizer has potassium chloride 2 mEq/mL 10 mL vials on back order and the company estimates a release date of August 2025.
- Nexuas has potassium chloride 10 mEq/50 mL premixed bags and 20 mEq/100 mL premixed bags on back order and the company estimates a release date of early-September 2025. The 10 mEq/100 mL premixed bags are on back order and the company estimates a release date of early-August 2025. The 20 mEq/50 mL premixed bags are on back order and the company cannot estimate a release date.

Updated

Updated July 29, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 3, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.